Clinical trials
Phase 4 Cross Infection trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 4 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mahidol University | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Bactiguard AB | 1 |
| Bayside Health | 1 |
| Centre for Infectious Disease Research in Zambia | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Harvard Pilgrim Health Care | 1 |
| Janssen-Cilag Ltd.,Thailand | 1 |
| Mashhad University of Medical Sciences | 1 |
| National University of Singapore | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cross Infection | 19 |
| Pneumonia, Ventilator-Associated | 3 |
| Critical Illness | 2 |
| Staphylococcal Infections | 2 |
| Urinary Tract Infections | 2 |
| Appendicitis | 1 |
| Bacterial Infections | 1 |
| Bacteriuria | 1 |
| COVID-19 | 1 |
| Cholecystitis | 1 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.